Fc receptor inhibition reduces susceptibility to oxidative stress in human RPE cells treated with bevacizumab, but not aflibercept

Mahdy Ranjbar, Max Philipp Brinkmann, Dorinja Zapf, Yoko Miura, Martin Rudolf, Salvatore Grisanti

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Fc receptor inhibition reduces susceptibility to oxidative stress in human RPE cells treated with bevacizumab, but not aflibercept'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science